Health

DeepCare debuts at IDS Cologne 2023

COLOGNE, Germany, March 14, 2023 /PRNewswire/ -- DeepCare, a leading AI solution provider for dental care, debuts its latest innovative products at the International Dental Show (IDS) inCologne, Germany, from March 14th to 18th, 2023. IDS is the world's largest and most influential dental exhibit...

2023-03-14 16:00 1719

Austco Augments Industry-leading Nurse Call and Healthcare Communications Solutions with 4D Imaging Radar Fall Detection by Vayyar

International partnership will see sensor installations in senior care facilities in all of Austco's operating regions, includingAustralia, the UK, Canada, and the US. DALLAS and TEL AVIV, Israel, March 13, 2023 /PRNewswire/ -- Austco , an international manufacturer of n...

2023-03-13 22:00 2213

Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction

SHANGHAI, March 13, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the survey results of bone marrow patient services provided by ...

2023-03-13 20:00 2074

Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors

SUZHOU, China, March 13, 2023 /PRNewswire/ -- On March 7th, 2023, Suzhou Porton Advanced Solutions Ltd. (Porton Advanced) and Bennu Biotherapeutics (Bennubio) announced a strategic partnership to advance cell and gene therapy R&D pipelines. The partnership aims to accelerate the development of T-...

2023-03-13 20:00 1720

AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease

TAIPEI, March 10, 2023 /PRNewswire/ -- AnnJi Pharmaceutical Co. (AnnJi) has entered into an exclusive license agreement with Avenue Therapeutics Inc. (Avenue, NASDAQ: ATXI) for the development and commercialization of AJ201 in the U.S.,Canada, European Union, Great Britain, and Israel for spinal ...

2023-03-10 19:00 1714

Success for Surglasses Technology! First AR Surgery Completed in the United States

TAICHUNG, Taiwan, March 10, 2023 /PRNewswire/ -- Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging. Surglasses has achieved a signifi...

2023-03-10 16:26 1852

Safeguard "Children of the Stars" - Soul App's New Campaign Inspires Young Users

SHANGHAI, March 9, 2023 /PRNewswire/ -- "Thank you all. It was heartwarming. (We will) keep going," said a message left by a parent of an autistic child in an online group chat party. In China, children with autism are also known as "children of the stars", due to the different way in which they...

2023-03-10 11:21 1773

Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing

BOSTON, March 9, 2023 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a$50 million Series B financing round, co-led by INCE Capital and Qiming Venture Partners, w...

2023-03-10 09:00 2014

Hugel Nominates Suk-yong Cha as Non-Executive Director

* Hugel's 22nd General shareholders' meeting to take place on March 30th * Proposed appointment of Suk-yong Cha as new non-executive director as an agenda item SEOUL, South Korea, March 9, 2023 /PRNewswire/ -- Hugel, a global total medical aesthetic company, announced onMarch 9th that it wil...

2023-03-09 23:00 2152

Chamlion, the world's first dental 3D printing service cloud platform will appear at the IDS

COLOGNE, Germany, March 9, 2023 /PRNewswire/ -- On March 14, Chamlion, a digital dental expert, will appear at the IDS inGermany, exhibiting the world's first dental 3D printing service cloud platform at booth K091 in Hall 11.3, providing one-stop solutions for global dental processing customers....

2023-03-09 22:00 2174

Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 17, 2023

BEIJING, March 9, 2023 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the fourth quarter a...

2023-03-09 19:45 3024

GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting

SHANGHAI, March 9, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today announced the results from phase I study of GFH312 (RIPK1 inhibitor) monotherapy will be presented as a poster at the 2023 ASC...

2023-03-09 19:00 1603

World-First, 45,000 patients study to develop AI-based "precision medicine" for migraine relief - collaboration between Healint and University of Geneva, Switzerland

PALO ALTO, Calif., March 9, 2023 /PRNewswire/ -- Healint, the developer and owner of Migraine Buddy – the world's largest migraine tracking and research platform used by more than 3 million people – is announcing a collaboration with the University ofGeneva.

2023-03-09 16:55 1685

Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas

Initiation of Phase I/II Clinical Trial (Starlight-1) Expected to Occur in Second Half of 2023 EMERYVILLE, Calif. and NEW YORK, March 8, 2023 /PRNewswire/ -- Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune ...

2023-03-09 05:15 1977

Decipher Fat Burning: A Breath Analyzer Achieved Funding Goal on Indiegogo in 1 Hour

SINGAPORE, March 8, 2023 /PRNewswire/ -- Singapore-based Tech startup Metanoia Sensing has announced a new breath analyzer 'MetaNose' to help people monitor their fat (lipid) burning status. The device also provides insights into the users' metabolic health risk such as diabetic related condition...

2023-03-09 00:00 2085

BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events

CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA , a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) by leveraging its proprietary Brain-Targeting RNAi Nanomedi...

2023-03-08 22:47 1861

Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise

LISBON, Portugal, March 8, 2023 /PRNewswire/ -- Hovione, the leader in spray drying and particle engineering, won the2023 CDMO Leadership Award across all six categories – capability, compatibility, expertise, quality, reliability and service across all thre...

2023-03-08 22:00 2002

The Next Generation of Smart home gym: Kickstarter Success - HooKee, to launch the Indiegogo Campaign

HONG KONG, March 7, 2023 /PRNewswire/ -- Halytus, the innovative smart home gym brand, is proud to announce the launch of its Indiegogo campaign on March 7th.  "Without the enthusiastic support of our backers, we couldn't have reached this tremendous milestone," said Dr. Zhong Shen, the co-founde...

2023-03-07 21:20 1953

MSCI ESG Updated I-Mab to "A" Rating

GAITHERSBURG, MD. and SHANGHAI, March 7, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that I-Mab has been granted "A" rating by MSCI (Morgan ...

2023-03-07 21:02 1827

AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract

NEW YORK, March 7, 2023 /PRNewswire/ – AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "Company" (Nasdaq: ANPC), a company with operations inthe United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commer...

2023-03-07 20:30 1570
1 ... 109110111112113114115 ... 280